Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α+thalassaemia

  1. D Herbert Opi
  2. Olivia Swann  Is a corresponding author
  3. Alexander Macharia
  4. Sophie Uyoga
  5. Gavin Band
  6. Carolyne M Ndila
  7. Ewen Harrison
  8. Mahamadou A Thera
  9. Abdoulaye K Kone
  10. Dapa A Diallo
  11. Ogobara K Doumbo
  12. Kirsten E Lyke
  13. Christopher Plowe
  14. Joann M Moulds
  15. Mohammed Shebbe
  16. Neema Mturi
  17. Norbert Peshu
  18. Kathryn Maitland
  19. Ahmed Raza
  20. Dominic P Kwiatkowski
  21. Kirk A Rockett
  22. Thomas Williams
  23. J Alexandra Rowe
  1. Kenya Medical Research Institute-Wellcome Trust Research Programme, Kenya
  2. University of Edinburgh, United Kingdom
  3. University of Oxford, United Kingdom
  4. University of Bamako, Mali
  5. University of Maryland, United States
  6. Lifeshare Blood Centers, United States

Abstract

Malaria has been a major driving force in the evolution of the human genome. In sub-Saharan African populations, two neighbouring polymorphisms in the Complement Receptor One (CR1) gene, named Sl2 and McCb, occur at high frequencies, consistent with selection by malaria. Previous studies have been inconclusive. Using a large case-control study of severe malaria in Kenyan children and statistical models adjusted for confounders, we estimate the relationship between Sl2 and McCb and malaria phenotypes, and find they have opposing associations. The Sl2 polymorphism is associated with markedly reduced odds of cerebral malaria and death, while the McCb polymorphism is associated with increased odds of cerebral malaria. We also identify an apparent interaction between Sl2 and α+thalassaemia, with the protective association of Sl2 greatest in children with normal α-globin. The complex relationship between these three mutations may explain previous conflicting findings, highlighting the importance of considering genetic interactions in disease-association studies.

Data availability

The following previously published data sets were used
    1. Rockett K
    2. Clarke GM
    3. Fitzpatrick K
    4. Hubbart C
    5. Jeffrys AE
    6. Rowlands K
    7. et al
    (2014) MalariaGEN Consortial Project 1
    Application for access to data: https://www.malariagen.net/data/terms-use/human-gwas-data.

Article and author information

Author details

  1. D Herbert Opi

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  2. Olivia Swann

    Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom
    For correspondence
    Olivia.Swann@ed.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7386-2849
  3. Alexander Macharia

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  4. Sophie Uyoga

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  5. Gavin Band

    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Carolyne M Ndila

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  7. Ewen Harrison

    Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Mahamadou A Thera

    Malaria Research and Training Centre, University of Bamako, Bamako, Mali
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2679-035X
  9. Abdoulaye K Kone

    Malaria Research and Training Centre, University of Bamako, Bamako, Mali
    Competing interests
    The authors declare that no competing interests exist.
  10. Dapa A Diallo

    Malaria Research and Training Centre, University of Bamako, Bamako, Mali
    Competing interests
    The authors declare that no competing interests exist.
  11. Ogobara K Doumbo

    Malaria Research and Training Centre, University of Bamako, Bamako, Mali
    Competing interests
    The authors declare that no competing interests exist.
  12. Kirsten E Lyke

    Division of Malaria Research, Institute for Global Health, University of Maryland, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Christopher Plowe

    Division of Malaria Research, Institute for Global Health, University of Maryland, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Joann M Moulds

    Lifeshare Blood Centers, Shreveport, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Mohammed Shebbe

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  16. Neema Mturi

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  17. Norbert Peshu

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  18. Kathryn Maitland

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  19. Ahmed Raza

    Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  20. Dominic P Kwiatkowski

    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  21. Kirk A Rockett

    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6369-9299
  22. Thomas Williams

    Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  23. J Alexandra Rowe

    Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7702-1892

Funding

Wellcome Trust (Senior Research Fellowship 091758)

  • Thomas Williams

Wellcome Trust (Senior Research Fellowship202800)

  • Thomas Williams

Wellcome Trust (Senior Research Fellowship084226)

  • J Alexandra Rowe

Wellcome Trust (203077)

  • D Herbert Opi

Wellcome Trust (84538)

  • D Herbert Opi

Wellcome Trust (101910/Z/13/Z)

  • Olivia Swann

Medical Research Council (G19/9)

  • Dominic P Kwiatkowski

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: This work involved analysing blood samples from patients with malaria and from healthy controls. Written informed consent was obtained from the parents or legal guardians of all participants. The Kenyan studies received ethical approval from the Kenya Medical Research Institute National Ethical Review Committee (approval number SCC1192 for the case-control study and SCC3149 for the longitudinal cohort study), and the Malian studies received ethical approval from the University of Bamako and the University of Maryland (approval number #0899139), and were conducted in accordance with the Declaration of Helsinki.

Copyright

© 2018, Opi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,674
    views
  • 212
    downloads
  • 24
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. D Herbert Opi
  2. Olivia Swann
  3. Alexander Macharia
  4. Sophie Uyoga
  5. Gavin Band
  6. Carolyne M Ndila
  7. Ewen Harrison
  8. Mahamadou A Thera
  9. Abdoulaye K Kone
  10. Dapa A Diallo
  11. Ogobara K Doumbo
  12. Kirsten E Lyke
  13. Christopher Plowe
  14. Joann M Moulds
  15. Mohammed Shebbe
  16. Neema Mturi
  17. Norbert Peshu
  18. Kathryn Maitland
  19. Ahmed Raza
  20. Dominic P Kwiatkowski
  21. Kirk A Rockett
  22. Thomas Williams
  23. J Alexandra Rowe
(2018)
Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α+thalassaemia
eLife 7:e31579.
https://doi.org/10.7554/eLife.31579

Share this article

https://doi.org/10.7554/eLife.31579

Further reading

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Felix Lankester, Tito J Kibona ... Sarah Cleaveland
    Research Article

    Lack of data on the aetiology of livestock diseases constrains effective interventions to improve livelihoods, food security and public health. Livestock abortion is an important disease syndrome affecting productivity and public health. Several pathogens are associated with livestock abortions but across Africa surveillance data rarely include information from abortions, little is known about aetiology and impacts, and data are not available to inform interventions. This paper describes outcomes from a surveillance platform established in Tanzania spanning pastoral, agropastoral and smallholder systems to investigate causes and impacts of livestock abortion. Abortion events were reported by farmers to livestock field officers (LFO) and on to investigation teams. Events were included if the research team or LFO could attend within 72 hr. If so, samples and questionnaire data were collected to investigate (a) determinants of attribution; (b) patterns of events, including species and breed, previous abortion history, and seasonality; (c) determinants of reporting, investigation and attribution; (d) cases involving zoonotic pathogens. Between 2017–2019, 215 events in cattle (n=71), sheep (n=44), and goats (n=100) were investigated. Attribution, achieved for 19.5% of cases, was significantly affected by delays in obtaining samples. Histopathology proved less useful than PCR due to rapid deterioration of samples. Vaginal swabs provided practical and sensitive material for pathogen detection. Livestock abortion surveillance, even at a small scale, can generate valuable information on causes of disease outbreaks, reproductive losses and can identify pathogens not easily captured through other forms of livestock disease surveillance. This study demonstrated the feasibility of establishing a surveillance system, achieved through engagement of community-based field officers, establishment of practical sample collection and application of molecular diagnostic platforms.

    1. Epidemiology and Global Health
    2. Genetics and Genomics
    Tianyu Zhao, Hui Li ... Li Chen
    Research Article

    Alzheimer’s disease (AD) is a complex degenerative disease of the central nervous system, and elucidating its pathogenesis remains challenging. In this study, we used the inverse-variance weighted (IVW) model as the major analysis method to perform hypothesis-free Mendelian randomization (MR) analysis on the data from MRC IEU OpenGWAS (18,097 exposure traits and 16 AD outcome traits), and conducted sensitivity analysis with six models, to assess the robustness of the IVW results, to identify various classes of risk or protective factors for AD, early-onset AD, and late-onset AD. We generated 400,274 data entries in total, among which the major analysis method of the IVW model consists of 73,129 records with 4840 exposure traits, which fall into 10 categories: Disease, Medical laboratory science, Imaging, Anthropometric, Treatment, Molecular trait, Gut microbiota, Past history, Family history, and Lifestyle trait. More importantly, a freely accessed online platform called MRAD (https://gwasmrad.com/mrad/) has been developed using the Shiny package with MR analysis results. Additionally, novel potential AD therapeutic targets (CD33, TBCA, VPS29, GNAI3, PSME1) are identified, among which CD33 was positively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. TBCA and VPS29 were negatively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. GNAI3 and PSME1 were negatively associated with the main outcome traits of AD, as well as with LOAD, but had no significant causal association with EOAD. The findings of our research advance our understanding of the etiology of AD.